Grey Wolf reels in $50M to ex­pand in­to au­toim­mune dis­eases

Grey Wolf Ther­a­peu­tics raised an­oth­er $50 mil­lion, which is set to ex­tend its run­way through 2026 and fund an­oth­er clin­i­cal tri­al, this time in au­toim­mune …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER